Browse All

Current Filters

CLEAR FILTER x

TITLE

Top-line Results From MaGic, a Phase Two Trial of Claseprubart (DNTH103), an Active C1s Inhibitor, in Generalized Myasthenia Gravis

Author:Peric, Stojan   Narayanaswami, Puspha   Smilowski, Marek   Slowik, Agnieszka   Gokhale, Sankalp   Briggs, Caitlin   Siddiqui, Uzma   Randhawa, Simrat   Truman, Matt   Hickey, Luke   Shelly, Shahar   Vu, Tuan   Vissing, John   

Session Name:S14: Updates on Myasthenia Gravis  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:S14.007  

Author Institution:University of Belgrade, Belgrade, Serbia  Beth Israel Deaconess Medical Center/Harvard Medical School, MA  Neurologia Slaska Centrum Medyczne, Poland  University Hospital, Krakow, Poland  Dianthus Therapeutics, NY  Rambam Medical Center, Israel  University of South Florida, Tampa, FL  University of Copenhagen, Denmark